trending Market Intelligence /marketintelligence/en/news-insights/trending/6TMBdT3fmeptjHxAoiSJgQ2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

J&J to acquire remaining stake in Google robotics collaboration Verb Surgical

Impact of COVID 19 on US Video Entertainment Trends

Case Study: Transforming Sales Enablement Data at a Global Advertising and Media Firm

Paypal Well-Positioned To Gain Share In COVID-Related Digital Payments Shift

Online Video Households Poised To Overtake Multichannel In US Forecast


J&J to acquire remaining stake in Google robotics collaboration Verb Surgical

Johnson & Johnson is acquiring the remaining stake in robotics and data science company Verb Surgical Inc., which the healthcare giant owns with Alphabet Inc. unit Verily Life Sciences LLC.

Verb Surgical is a 50-50 strategic collaboration with the life sciences arm of J&J's unit Ethicon Endo-Surgery Inc. and Verily, which was formed out of Google LLC, according to data from S&P Global Market Intelligence.

The privately held company is a digital surgery platform combining robotics, advanced visualization, advanced instrumentation and data analytics. The partnership was conceived in 2015 to develop a robotic surgery platform by 2020.

New Brunswick, N.J.-based J&J said Verb Surgical's expertise will help bolster its digital surgery portfolio. The transaction is expected to close in the first half of 2020, subject to antitrust clearance and customary closing conditions, J&J said in a Dec. 20 press release.

Financial terms of this transaction were not disclosed.